Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

0.7012
+0.03905.89%
Pre-market: 0.71000.0088+1.25%04:25 EDT
Volume:5.92M
Turnover:4.17M
Market Cap:194.93M
PE:-1.41
High:0.7300
Open:0.6630
Low:0.6601
Close:0.6622
52wk High:2.55
52wk Low:0.5261
Shares:278.00M
Float Shares:245.00M
Volume Ratio:0.58
T/O Rate:2.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4975
EPS(LYR):-0.2582
ROE:-547.87%
ROA:-49.87%
PB:6.24
PE(LYR):-2.72

Loading ...

Humacyte says Israel accepts Symvess marketing application, sets 180-day review period

Reuters
·
Apr 21

Humacyte announces annual shareholder meeting

Reuters
·
Apr 18

Humacyte Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 08

Humacyte Inc. : Barclays Cuts Target Price to $1.5 From $3.5

THOMSON REUTERS
·
Apr 08

Largest borrow rate increases among liquid names

TIPRANKS
·
Apr 07

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Humacyte (HUMA)

TIPRANKS
·
Apr 02

Humacyte Cut to Speculative Buy From Buy by Benchmark

Dow Jones
·
Mar 31

Humacyte downgraded to Speculative Buy from Buy at Benchmark

TIPRANKS
·
Mar 31

Humacyte Inc : Benchmark Cuts to Speculative Buy From Buy; Cuts Target Price to $1 From $10

THOMSON REUTERS
·
Mar 31

Benchmark Downgrades Humacyte to Speculative Buy From Buy, Adjusts Price Target to $1 From $11

MT Newswires Live
·
Mar 31

Humacyte Is Maintained at Neutral by Piper Sandler

Dow Jones
·
Mar 31

Humacyte price target lowered to $1 from $3 at Piper Sandler

TIPRANKS
·
Mar 30

Humacyte Is Maintained at Buy by BTIG

Dow Jones
·
Mar 27

Humacyte Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 27

Humacyte posts bigger-than-expected Q4 loss

Reuters
·
Mar 27

Humacyte FY2025 net loss narrows to $40.8 million; revenue rises to $2.0 million

Reuters
·
Mar 27

Humacyte Q4 EPS $(0.13), Inline, Sales $467.000K Miss $1.343M Estimate

Benzinga Earnings
·
Mar 27

BRIEF-Humacyte Q4 Basic EPS USD -0.13

Reuters
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 27

BRIEF-Humacyte Appoints Rick Mcelheny As Senior Vice President Of Business Development

Reuters
·
Mar 26